Hemocompatibility Testing
Hemocompatibility testing evaluates the interactions between medical devices and blood components to ensure they do not cause adverse effects such as hemolysis (red blood cell damage), thrombosis (blood clot formation), or immune system activation. This testing is critical for externally communicating devices and implant devices, including vascular stents, catheters, heart valves, dialysis equipment, and blood collection sets.
Regulatory agencies such as the FDA (ISO 10993-4) and EU MDR (Annex I, General Safety and Performance Requirements) mandate hemocompatibility assessments to demonstrate device safety. At Meditronics (a brand of STEMart), we provide ISO 10993-4-compliant hemocompatibility testing to support your device's regulatory approval and patient safety.
Our Service
Meditronics conducts hemocompatibility testing following ISO 10993-4, covering multiple aspects of blood-device interactions:
Hemolysis Testing
Evaluates the potential for device materials to damage red blood cells, a crucial test for devices with blood contact.
Coagulation Assay
Measures effects on blood clotting mechanisms through prothrombin time (PT), activated partial thromboplastin time (aPTT), and other coagulation parameters.
Platelet Adhesion Test
Assesses platelet activation and adhesion to device surfaces, critical for cardiovascular devices.
Complement Activation Test
Detects activation of the complement system, which can trigger inflammatory responses, such as: C3a, C5a levels.
Thrombogenicity Assessment
Evaluates the potential for blood clot formation using in vivo models.
Each test is carefully selected based on the device's intended use, duration of blood contact, and nature of blood interaction to provide the most relevant safety data for successful regulatory approval and market entry.
Why Choose Meditronics?
At Meditronics, we understand the complex regulatory landscape for medical devices. Our testing services fully comply with FDA, EU MDR, and ISO standards. Our scientific rigor, regulatory expertise, and commitment to quality ensure that your medical devices meet all necessary safety requirements. From initial test selection to final report generation, we provide end-to-end support for your hemocompatibility testing needs.
✔ Regulatory Support
Our experts guide you through the entire testing process and help prepare documentation for regulatory submissions.
✔ Customized Testing Strategies
Whether your device contacts skin, mucous membranes, or deeper tissues, we tailor the test protocol to reflect real-world use conditions.
✔ Advanced Facilities
Our state-of-the-art laboratories are equipped with the latest technologies for accurate and reliable testing.
✔ Fast Turnaround and Global Support
We understand time-to-market pressures and deliver results within agreed timelines.
Contact Meditronics today to discuss your medical device testing requirements and learn how our hemocompatibility testing services can support your product development and regulatory strategy.
Reference
- Maria A. A. R., etc. (2023). "In vitro hemocompatibility and genotoxicity evaluation of dual-labeled [99mTc]Tc-FITC-silk fibroin nanoparticles for biomedical applications." Pharmaceuticals. 16(2), 248. Published under an open access Creative Common CC BY 4.0 license.
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Need More Information or Request A Quotation?
Related Links
